FONTANA, M.C., G. MARCONI, J.D.M. FEENSTRA, E. FONZI, C. PAPAYANNIDIS, A.G.L. DI RORA, A. PADELLA, V. SOLLI, E. FRANCHINI, E. OTTAVIANI, A. FERRARI, C. BALDAZZI, N. TESTONI, I. IACOBUCCI, S. SOVERINI, T. HAFERLACH, V. GUADAGNUOLO, Lukáš SEMERÁD, Michael DOUBEK, M. STEURER, Zdeněk RÁČIL, S. PAOLINI, M. MANFRINI, M. CAVO, G. SIMONETTI, R. KRALOVICS and G. MARTINELLI. Chromothripsis in acute myeloid leukemia: biological features and impact on survival. Online. Leukemia. London: Nature Publishing Group, 2018, vol. 32, No 7, p. 1609-1620. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0035-y. [citováno 2024-04-24]
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Chromothripsis in acute myeloid leukemia: biological features and impact on survival
Authors FONTANA, M.C. (380 Italy, guarantor), G. MARCONI (380 Italy), J.D.M. FEENSTRA (40 Austria), E. FONZI (380 Italy), C. PAPAYANNIDIS (380 Italy), A.G.L. DI RORA (380 Italy), A. PADELLA (380 Italy), V. SOLLI (380 Italy), E. FRANCHINI (380 Italy), E. OTTAVIANI (380 Italy), A. FERRARI (380 Italy), C. BALDAZZI (380 Italy), N. TESTONI (380 Italy), I. IACOBUCCI (380 Italy), S. SOVERINI (380 Italy), T. HAFERLACH (380 Italy), V. GUADAGNUOLO (380 Italy), Lukáš SEMERÁD (203 Czech Republic, belonging to the institution), Michael DOUBEK (203 Czech Republic, belonging to the institution), M. STEURER, Zdeněk RÁČIL (203 Czech Republic, belonging to the institution), S. PAOLINI (40 Austria), M. MANFRINI (380 Italy), M. CAVO (380 Italy), G. SIMONETTI (380 Italy), R. KRALOVICS (40 Austria) and G. MARTINELLI (380 Italy)
Edition Leukemia, London, Nature Publishing Group, 2018, 0887-6924.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 9.944
RIV identification code RIV/00216224:14110/18:00103518
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1038/s41375-018-0035-y
UT WoS 000438062500013
Keywords in English genomic instability; cancer genomes; prostate-cancer; tp53 mutations; classification; prognosis; aml; recommendations; rearrangements; chromosomes
Tags 14110212, EL OK, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 10/2/2019 13:46.
Abstract
Chromothripsis is a one-step genome-shattering catastrophe resulting from disruption of one or few chromosomes in multiple fragments and consequent random rejoining and repair. This study defines incidence of chromothripsis in 395 newly diagnosed adult acute myeloid leukemia (AML) patients from three institutions, its impact on survival and its genomic background. SNP 6.0 or CytoscanHD Array (Affymetrix (R)) were performed on all samples. We detected chromothripsis with a custom algorithm in 26/395 patients. Patients harboring chromothripsis had higher age (p = 0.002), ELN high risk (HR) (p < 0.001), lower white blood cell (WBC) count (p = 0.040), TP53 loss, and/or mutations (p < 0.001) while FLT3 (p = 0.025), and NPM1 (p = 0.032) mutations were mutually exclusive with chromothripsis. Chromothripsis-positive patients showed a worse overall survival (OS) (p < 0.001) compared with HR patients (p = 0.011) and a poor prognosis in a COX-HR optimal regression model. Chromothripsis presented the hallmarks of chromosome instability [i.e., TP53 alteration, 5q deletion, higher mean of copy number alteration (CNA), complex karyotype, alterations in DNA repair, and cell cycle] and focal deletions on chromosomes 4, 7, 12, 16, and 17. CBA. FISH showed that chromothripsis is associated with marker, derivative, and ring chromosomes. In conclusion, chromothripsis frequently occurs in AML (6.6%) and influences patient prognosis and disease biology.
PrintDisplayed: 24/4/2024 10:27